semaglutide in kidney disease Ozempic Approval for Reducing Semaglutide in patients with overweight

The full Wegovy escalation runs through 2.4 mg, and as of March 2026, an FDA-approved higher dose of 7.2 mg is now available (Wegovy HD)

Sip fluids slowly, particularly if experiencing nausea, as small frequent amounts are often better tolerated than large volumes

It works by: Slowing digestion so that blood sugar rises more gradually after a meal

Retrospective Study In a retrospective study of more than 83,000 obese individuals, semaglutide was associated with a more than 50% lower incidence of alcohol use disorder (AUD) over a period of 12 months, regardless of age, gender, race, or diabetes status

If you have diabetes and are taking Ozempic for medical reasons rather than weight loss, the decision to stop during egg freezing requires your healthcare providers input